Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers

Chapter 1_ Introduction of the renin-angiotensin-aldosterone system (RAAS).- Chapter 2_ Role of anti-hypertensive agents in cardiovascular disorders.- Chapter 3_ (ACE) Angiotensin-converting enzyme inhibitors: Preferred RAAS inhibitor in high-risk patients as compared to angiotensin receptor blockers (ARBs).- Chapter 4_ Role of (ACE) angiotensin-converting enzyme inhibitors in transforming renin-angiotensin system.- Chapter 5_ The effect of (ACE) Angiotensin-converting enzyme inhibitors vs angiotensin receptor blockers on insulin resistance in hypertensive patients.- Chapter 6_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure.- Chapter 7_ Immunomodulator activity of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients.- Chapter 8_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peripheral artery disease.- Chapter 9_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in covid-19 patients.- Chapter 10_ Recent trends in the management of hypertension through RAAS inhibition.

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Doenças e desvios
• Pesquisa médica
• Farmacologia
• Química
• Medicina pré-clínica: ciências básicas
• Terapia e terapêutica

Renin-angiotensin-aldosterone system;Angiotensin-converting enzyme inhibitors;angiotensin receptor blockers;cardiovascular disorder;myocardial infarction